Identification of susceptibility loci for cervical carcinoma by genome scan of affected sib-pairs

Human Molecular Genetics

Volumn 15, Issue 22, 2006, Pages 3351-3360

  Engelmark, Malin T ^a   Ivansson, Emma L ^a   Magnusson, Jessica J ^a   Gustavsson, Inger M ^a   Beskow, Anna H ^a   Magnusson, Patrik K E ^a,b   Gyllensten, Ulf B ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN; THYMIC STROMAL COTRANSPORTER; UNCLASSIFIED DRUG;

ALLELE; ARTICLE; CANCER INHIBITION; CARCINOGENESIS; CHROMOSOME NUMBER; ESOPHAGUS CANCER; FEMALE; GENE LOCUS; GENE MAPPING; GENETIC LINKAGE; GENETIC SUSCEPTIBILITY; HODGKIN DISEASE; HOST RESISTANCE; HUMAN; IMMUNE RESPONSE; LINKAGE ANALYSIS; MAJOR CLINICAL STUDY; MICROSATELLITE MARKER; NONPARAMETRIC TEST; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; SIBLING; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL ANALYSIS; UTERINE CERVIX CARCINOMA; VIRUS INFECTION;

COMPUTATIONAL BIOLOGY; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOME, HUMAN; GENOTYPE; HUMANS; MICROSATELLITE REPEATS; POLYMORPHISM, SINGLE NUCLEOTIDE; SIBLINGS; SYMPORTERS; UTERINE CERVICAL NEOPLASMS;

HUMAN PAPILLOMAVIRUS;

EID: 33750426247     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddl411     Document Type: Article

References (76)

1. Parkin, D.M., Bray, F., Ferlay, J. and Pisani, P. (2005) Global cancer statistics. CA Cancer J. Clin., 55, 74-108.
2. Walboomers, J.M., Jacobs, M.V., Manos, M.M., Bosch, F.X., Kummer, J.A., Shah, K.V., Snijders, P.J., Peto, J., Meijer, C.J. and Munoz, N. (1999) Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J. Pathol., 189, 12-19.
3. Bosch, F.X., Lorincz, A., Munoz, N., Meijer, C.J. and Shah, K.V. (2002) The causal relation between human papillomavirus and cervical cancer. J. Clin. Pathol., 55, 244-265.
4. Dyson, N., Howley, P.M., Munger, K. and Harlow, E. (1989) The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science, 243, 934-937.
5. Thomas, M., Matlashewski, G., Pim, D. and Banks, L. (1996) Induction of apoptosis by p53 is independent of its oligomeric state and can be abolished by HPV-18 E6 through ubiquitin mediated degradation. Oncogene, 13, 265-273.
6. Harper, D.M., Franco, E.L., Wheeler, C., Ferris, D.G., Jenkins, D., Schuind, A., Zahaf, T., Innis, B., Naud, P., De Carvalho, N.S. et al. (2004) Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: A randomised controlled trial. Lancet, 364, 1757-1765.
7. Villa, L.L., Costa, R.L., Petta, C.A., Andrade, R.P., Ault, K.A., Giuliano, A.R., Wheeler, C.M., Koutsky, L.A., Malm, C., Lehtinen, M. et al. (2005) Prophylactic quadrivalent human papillomavirus (types 6, 11, 16 and 18) L1 virus-like particle vaccine in young women: A randomised double-blind placebo-controlled multicentre phase II efficacy trial. Lancet Oncol., 6, 271-278.
8. Galloway, D.A. (2003) Papillomavirus vaccines in clinical trials. Lancet Infect. Dis., 3, 469-475.
9. Hillemanns, P., Ellerbrock, T.V., McPhillips, S., Dole, P., Alperstein, S., Johnson, D., Sun, X.W., Chiasson, M.A. and Wright, T.C., Jr. (1996) Prevalence of anal human papillomavirus infection and anal cytologic abnormalities in HIV-seropositive women. AIDS, 10, 1641-1647.
10. Palefsky, J.M., Holly, E.A., Ralston, M.L. and Jay, N. (1998) Prevalence and risk factors for human papillomavirus infection of the anal canal in human immunodeficiency virus (HIV)-positive and HIV-negative homosexual men. J. Infect. Dis., 177, 361-367.
11. Critchlow, C.W., Hawes, S.E., Kuypers, J.M., Goldbaum,G.M., Holmes, K.K., Surawicz, C.M. and Kiviat, N.B. (1998) Effect of HIV infection on the natural history of anal human papillomavirus infection. AIDS, 12, 1177-1184.
12. Fairley, C.K., Chen, S., Tabrizi, S.N., McNeil, J., Becker, G., Walker, R., Atkins, R.C., Thomson, N., Allan, P., Woodburn, C. et al. (1994) Prevalence of HPV DNA in cervical specimens in women with renal transplants: A comparison with dialysis-dependent patients and patients with renal impairment. Nephrol. Dial. Transplant., 9, 416-420.
13. Ozsaran, A.A., Ates, T., Dikmen, Y., Zeytinoglu, A., Terek, C., Erhan, Y., Ozacar, T. and Bilgic, A. (1999) Evaluation of the risk of cervical intraepithelial neoplasia and human papilloma virus infection in renal transplant patients receiving immunosuppressive therapy. Eur. J. Gynaecol. Oncol., 20, 127-130.
14. Bontkes, H.J., de Gruijl, T.D., Walboomers, J.M., van den Muysenberg, A.J., Gunther, A.W., Scheper, R.J., Meijer, C.J. and Kummer, J.A. (1997) Assessment of cytotoxic T-lymphocyte phenotype using the specific markers granzyme B and TIA-1 in cervical neoplastic lesions. Br. J. Cancer, 76, 1353-1360.
15. Alexander, M., Salgaller, M.L., Celis, E., Sette, A., Barnes, W.A., Rosenberg, S.A. and Steller, M.A. (1996) Generation of tumor-specific cytolytic T lymphocytes from peripheral blood of cervical cancer patients by in vitro stimulation with a synthetic human papillomavirus type 16 E7 epitope. Am. J. Obstet. Gynecol., 175, 1586-1593.
16. Evans, E.M., Man, S., Evans, A.S. and Borysiewicz, L.K. (1997) Infiltration of cervical cancer tissue with human papillomavirus-specific cytotoxic T-lymphocytes. Cancer Res., 57, 2943-2950.
17. Beskow, A.H. and Gyllensten, U.B. (2002) Host genetic control of HPV 16 titer in carcinoma in situ of the cervix uteri. Int. J. Cancer, 101, 526-531.
18. Dalstein, V., Riethmuller, D., Pretet, J.L., Le Bail Carval, K., Sautiere, J.L., Carbillet, J.P., Kantelip, B., Schaal, J.P. and Mougin, C. (2003) Persistence and load of high-risk HPV are predictors for development of high-grade cervical lesions: A longitudinal French cohort study. Int. J. Cancer, 106, 396-403.
19. Ho, G.Y., Burk, R.D., Klein, S., Kadish, A.S., Chang, C.J., Palan, P., Basu, J., Tachezy, R., Lewis, R. and Romney, S. (1995) Persistent genital human papillomavirus infection as a risk factor for persistent cervical dysplasia. J. Natl Cancer Inst., 87, 1365-1371.
20. Schlecht, N.F., Kulaga, S., Robitaille, J., Ferreira, S., Santos, M., Miyamura, R.A., Duarte-Franco, E., Rohan, T.E., Ferenczy, A., Villa, L.L. et al. (2001) Persistent human papillomavirus infection as a predictor of cervical intraepithelial neoplasia. Jama, 286, 3106-3114.
21. Magnusson, P.K., Sparen, P. and Gyllensten, U.B. (1999) Genetic link to cervical tumours. Nature, 400, 29-30.
22. Magnusson, P.K., Lichtenstein, P. and Gyllensten, U.B. (2000) Heritability of cervical tumours. Int. J. Cancer, 88, 698-701.
23. Zoodsma, M., Nolte, I.M., Te Meerman, G.J., De Vries, E.G. and Van der Zee, A.G. (2005) HLA genes and other candidate genes involved in susceptibility for (pre)neoplastic cervical disease. Int. J. Oncol., 26, 769-784.
24. Lander, E.S. and Schork, N.J. (1994) Genetic dissection of complex traits. Science, 265, 2037-2048.
25. Horikawa, Y., Oda, N., Cox, N.J., Li, X., Orho-Melander, M., Hara, M., Hinokio, Y., Lindner, T.H., Mashima, H., Schwarz, P.E. et al. (2000) Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus. Nat. Genet., 26, 163-175.
26. Hugot, J.P., Chamaillard, M., Zouali, H., Lesage, S., Cezard, J.P., Belaiche, J., Almer, S., Tysk, C., O'Morain, C.A., Gassull, M. et al. (2001) Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature, 411, 599-603.
27. Prokunina, L., Castillejo-Lopez, C., Oberg, F., Gunnarsson, I., Berg, L., Magnusson, V., Brookes, A.J., Tentler, D., Kristjansdottir, H., Grondal, G. et al. (2002) A regulatory polymorphism in PDCD1 is associated with susceptibility to systemic lupus erythematosus in humans. Nat. Genet., 32, 666-669.
28. Engelmark, M., Beskow, A., Magnusson, J., Erlich, H. and Gyllensten, U. (2004) Affected sib-pair analysis of the contribution of HLA class I and class II loci to development of cervical cancer. Hum. Mol. Genet., 13, 1951-1958.
29. Ramoz, N., Rueda, L.A., Bouadjar, B., Favre, M. and Orth, G. (1999) A susceptibility locus for epidermodysplasia verruciformis, an abnormal predisposition to infection with the oncogenic human papillomavirus type 5, maps to chromosome 17qter in a region containing a psoriasis locus. J. Invest. Dermatol., 112, 259-263.
30. Kong, A., Gudbjartsson, D.F., Sainz, J., Jonsdottir, G.M., Gudjonsson, S.A., Richardsson, B., Sigurdardottir, S., Barnard, J., Hallbeck, B., Masson, G. et al. (2002) A high-resolution recombination map of the human genome. Nat. Genet., 31, 241-247.
31. Goudie, D.R., Yuille, M.A., Leversha, M.A., Furlong, R.A., Carter, N.P., Lush, M.J., Affara, N.A. and Ferguson-Smith, M.A. (1993) Multiple self-healing squamous epitheliomata (ESS1) mapped to chromosome 9q22-q31 in families with common ancestry. Nat. Genet., 3, 165-169.
32. Farndon, P.A., Del Mastro, R.G., Evans, D.G. and Kilpatrick, M.W. (1992) Location of gene for Gorlin syndrome. Lancet, 339, 581-582.
33. Xia, Y., Hwang, L.Y., Cobb, M.H. and Baer, R. (1994) Products of the TAL2 oncogene in leukemic T cells: BHLH phosphoproteins with DNA-binding activity. Oncogene, 9, 1437-1446.
34. Wang, Z., Shen, D., Parsons, D.W., Bardelli, A., Sager, J., Szabo, S., Ptak, J., Silliman, N., Peters, B.A., van der Heijden, M.S. et al. (2004) Mutational analysis of the tyrosine phosphatome in colorectal cancers. Science, 304, 1164-1166.
35. Smith, C.A., Gruss, H.J., Davis, T., Anderson, D., Farrah, T., Baker, E., Sutherland, G.R., Brannan, C.I., Copeland, N.G., Jenkins, N.A. et al. (1993) CD30 antigen, a marker for Hodgkin's lymphoma, is a receptor whose ligand defines an emerging family of cytokines with homology to TNF. Cell, 73, 1349-1360.
36. Miura, K., Suzuki, K., Tokino, T., Isomura, M., Inazawa, J., Matsuno, S. and Nakamura, Y. (1996) Detailed deletion mapping in squamous cell carcinomas of the esophagus narrows a region containing a putative tumor suppressor gene to about 200 kilobases on distal chromosome 9q. Cancer Res., 56, 1629-1634.
37. Nishiyama, H., Takahashi, T., Kakehi, Y., Habuchi, T. and Knowles, M.A. (1999) Homozygous deletion at the 9q32-33 candidate tumor suppressor locus in primary human bladder cancer. Genes Chromosomes Cancer, 26, 171-175.
38. Dote, H., Toyooka, S., Tsukuda, K., Yano, M., Ouchida, M., Doihara, H., Suzuki, M., Chen, H., Hsieh, J.T., Gazdar, A.F. et al. (2004) Aberrant promoter methylation in human DAB2 interactive protein (hDAB2IP) gene in breast cancer. Clin. Cancer Res., 10, 2082-2089.
39. Yano, M., Toyooka, S., Tsukuda, K., Dote, H., Ouchida, M., Hanabata, T., Aoe, M., Date, H., Gazdar, A.F. and Shimizu, N. (2005) Aberrant promoter methylation of human DAB2 interactive protein (hDAB2IP) gene in lung cancers. Int. J. Cancer, 113, 59-66.
40. Dote, H., Toyooka, S., Tsukuda, K., Yano, M., Ota, T., Murakami, M., Naito, M., Toyota, M., Gazdar, A.F. and Shimizu, N. (2005) Aberrant promoter methylation in human DAB2 interactive protein (hDAB2IP) gene in gastrointestinal tumour. Br. J. Cancer, 92, 1117-1125.
41. Nishiwaki, T., Daigo, Y., Kawasoe, T. and Nakamura, Y. (2000) Isolation and mutational analysis of a novel human cDNA, DEC1 (deleted in esophageal cancer 1), derived from the tumor suppressor locus in 9q32. Genes Chromosomes Cancer, 27, 169-176.
42. Bluteau, O., Jeannot, E., Bioulac-Sage, P., Marques, J.M., Blanc, J.F., Bui, H., Beaudoin, J.C., Franco, D., Balabaud, C., Laurent-Puig, P. et al. (2002) Bi-allelic inactivation of TCF1 in hepatic adenomas. Nat. Genet., 32, 312-315.
43. Zani, V.J., Asou, N., Jadayel, D., Heward, J.M., Shipley, J., Nacheva, E., Takasuki, K., Catovsky, D. and Dyer, M.J. (1996) Molecular cloning of complex chromosomal translocation t(8;14;12)(q24.1;q32.3;q24.1) in a Burkitt lymphoma cell line defines a new gene (BCL7A) with homology to caldesmon. Blood, 87, 3124-3134.
44. Nath, S.K., Quintero-Del-Rio, A.I., Kilpatrick, J., Feo, L., Ballesteros, M. and Harley, J.B. (2004) Linkage at 12q24 with systemic lupus erythematosus (SLE) is established and confirmed in Hispanic and European American families. Am. J. Hum. Genet., 74, 73-82.
45. Mao, M., Biery, M.C., Kobayashi, S.V., Ward, T., Schimmack, G., Burchard, J., Schelter, J.M., Dai, H., He, Y.D. and Linsley, P.S. (2004) T lymphocyte activation gene identification by coregulated expression on DNA microarrays. Genomics, 83, 989-999.
46. Dillon, S.R., Sprecher, C., Hammond, A., Bilsborough, J., Rosenfeld-Franklin, M., Presnell, S.R., Haugen, H.S., Maurer, M., Harder, B., Johnston, J. et al. (2004) Interleukin 31, a cytokine produced by activated T cells, induces dermatitis in mice. Nat. Immunol., 5, 752-760.
47. Cleton-Jansen, A.M., Callen, D.F., Seshadri, R., Goldup, S., McCallum, B., Crawford, J., Powell, J.A., Settasatian, C., van Beerendonk, H., Moerland, E.W. et al. (2001) Loss of heterozygosity mapping at chromosome arm 16q in 712 breast tumors reveals factors that influence delineation of candidate regions. Cancer Res., 61, 1171-1177.
48. Tsuda, H., Oda, T., Sakamoto, M. and Hirohashi, S. (1992) Different pattern of chromosomal allele loss in multiple hepatocellular carcinomas as evidence of their multifocal origin. Cancer Res., 52, 1504-1509.
49. Sato, M., Mori, Y., Sakurada, A., Fukushige, S., Ishikawa, Y., Tsuchiya, E., Saito, Y., Nukiwa, T., Fujimura, S. and Horii, A. (1998) Identification of a 910-kb region of common allelic loss in chromosome bands 16q24.1-q24.2 in human lung cancer. Genes Chromosomes Cancer, 22, 1-8.
50. Mori, Y., Matsunaga, M., Abe, T., Fukushige, S., Miura, K., Sunamura, M., Shiiba, K., Sato, M., Nukiwa, T. and Horii, A. (1999) Chromosome band 16q24 is frequently deleted in human gastric cancer. Br. J. Cancer, 80, 556-562.
51. Powell, J.A., Gardner, A.E., Bais, A.J., Hinze, S.J., Baker, E.,Whitmore, S., Crawford, J., Kochetkova, M., Spendlove, H.E., Doggett, N.A. et al. (2002) Sequencing, transcript identification, and quantitative gene expression profiling in the breast cancer loss of heterozygosity region 16q24.3 reveal three potential tumor-suppressor genes. Genomics, 80, 303-310.
52. Kochetkova, M., McKenzie, O.L., Bais, A.J., Martin, J.M., Secker, G.A., Seshadri, R., Powell, J.A., Hinze, S.J., Gardner, A.E., Spendlove, H.E. et al. (2002) CBFA2T3 (MTG16) is a putative breast tumor suppressor gene from the breast cancer loss of heterozygosity region at 16q24.3. Cancer Res., 62, 4599-4604.
53. Chen, C., Kim, M.G., Soo Lyu, M., Kozak, C.A., Schwartz, R.H. and Flomerfelt, F.A. (2000) Characterization of the mouse gene, human promoter and human cDNA of TSCOT reveals strong interspecies homology. Biochim. Biophys. Acta, 1493, 159-169.
54. Holmans, P. (1993) Asymptotic properties of affected-sib-pair linkage analysis. Am. J. Hum. Genet., 52, 362-374.
55. Kruglyak, L., Daly, M.J., Reeve-Daly, M.P. and Lander, E.S. (1996) Parametric and nonparametric linkage analysis: A unified multipoint approach. Am. J. Hum. Genet., 58, 1347-1363.
56. Houlston, R.S. and Tomlinson, I.P. (2000) Detecting low penetrance genes in cancer: The way ahead. J. Med. Genet., 37, 161-167.
57. Risch, N. (1990) Linkage strategies for genetically complex traits. II. The power of affected relative pairs. Am. J. Hum. Genet., 46, 229-241.
58. Cordell, H.J., Todd, J.A., Bennett, S.T., Kawaguchi, Y. and Farrall, M. (1995) Two-locus maximum lod score analysis of a multifactorial trait: joint consideration of IDDM2 and IDDM4 with IDDM1 in type 1 diabetes. Am. J. Hum. Genet., 57, 920-934.
59. Zerba, K.E., Ferrell, R.E. and Sing, C.F. (2000) Complex adaptive systems and human health: The influence of common genotypes of the apolipoprotein E (ApoE) gene polymorphism and age on the relational order within a field of lipid metabolism traits. Hum. Genet., 107, 466-475.
60. Cordell, H.J. (2001) Sample size requirements to control for stochastic variation in magnitude and location of allele-sharing linkage statistics in affected sibling pairs. Ann. Hum. Genet., 65, 491-502.
61. Phillips, P.C. (1998) The language of gene interaction. Genetics, 149, 1167-1171.
62. Marchini, J., Donnelly, P. and Cardon, L.R. (2005) Genome-wide strategies for detecting multiple loci that influence complex diseases. Nat. Genet., 37, 413-417.
63. Cordell, H.J. (2002) Epistasis: What it means, what it doesn't mean, and statistical methods to detect it in humans. Hum. Mol. Genet., 11, 2463-2468.
64. Zoodsma, M., Nolte, I.M., Schipper, M., Oosterom, E., van der Steege, G., de Vries, E.G., te Meerman, G.J. and van der Zee, A.G. (2005) Analysis of the entire HLA region in susceptibility for cervical cancer: a comprehensive study. J. Med. Genet., 42, e49.
65. Kim, M.G., Flomerfelt, F.A., Lee, K.N., Chen, C. and Schwartz, R.H. (2000) A putative 12 transmembrane domain cotransporter expressed in thymic cortical epithelial cells. J. Immunol., 164, 3185-3192.
66. Zuniga-Pflucker, J.C. (2004) T-cell development made simple. Nat. Rev. Immunol., 4, 67-72.
67. Syrjanen, K., Pyrhonen, S., Aukee, S. and Koskela, E. (1982) Squamous cell papilloma of the esophagus: A tumour probably caused by human papilloma virus (HPV). Diagn. Histopathol., 5, 291-296.
68. Markowitz, L., Dunne, E. and Gilsdorf, J. (2005) Development of recommendations for HPV vaccine use in the United States. 22nd International Papillomavirus Conference and Clinical Workshop 2005. Vancouver B.C., Canada.
69. Kast, W.M., Brandt, R.M., Drijfhout, J.W. and Melief, C.J. (1993) Human leukocyte antigen-A2.1 restricted candidate cytotoxic T lymphocyte epitopes of human papillomavirus type 16 E6 and E7 proteins identified by using the processing-defective human cell line T2. J. Immunother., 14, 115-120.
70. Beverley, P.C., Sadovnikova, E., Zhu, X., Hickling, J., Gao, L., Chain, B., Collins, S., Crawford, L., Vousden, K. and Stauss, H.J. (1994) Strategies for studying mouse and human immune responses to human papillomavirus type 16. Ciba Found Symp., 187, 78-86. Discussion 86-96.
71. Risch, N. (1990) Linkage strategies for genetically complex traits. III. The effect of marker polymorphism on analysis of affected relative pairs. Am. J. Hum. Genet., 46, 242-253.
72. Cordell, H.J. (2004) Bias toward the null hypothesis in model-free linkage analysis is highly dependent on the test statistic used. Am. J. Hum. Genet., 74, 1294-1302.
73. Lander, E. and Kruglyak, L. (1995) Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results. Nat. Genet., 11, 241-247.
74. Nyholt, D.R. (2000) All LODs are not created equal. Am. J. Hum. Genet., 67, 282-288.
75. Sawcer, S., Jones, H.B., Judge, D., Visser, F., Compston, A., Goodfellow, P.N. and Clayton, D. (1997) Empirical genomewide significance levels established by whole genome simulations. Genet. Epidemiol., 14, 223-229.
76. Weeks, D.E. and Lathrop, G.M. (1995) Polygenic disease: Methods for mapping complex disease traits. Trends Genet., 11, 513-519.